(CNQ) Canadian Natural Resources - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA1363851017
Stock:
Total Rating 51
Risk 78
Buy Signal 1.08
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | 2.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 49.53 |
| Character TTM | |
|---|---|
| Beta | 0.284 |
| Beta Downside | 1.484 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.85% |
| CAGR/Max DD | 0.54 |
EPS (Earnings per Share)
Revenue
Description: CNQ Canadian Natural Resources
Canadian Natural Resources Limited engages in the acquisition, exploration, development, production, marketing, and sale of crude oil, natural gas, and natural gas liquids (NGLs) in Western Canada, the United Kingdom sector of the North Sea, and Offshore Africa. The company offers light and medium crude oil, primary heavy crude oil, Pelican Lake heavy crude oil, bitumen (thermal oil), and synthetic crude oil (SCO). Its midstream assets include two crude oil pipeline systems; and a 50% working interest in an 84-megawatt cogeneration plant at Primrose. The company was formerly known as AEX Minerals Corporation and changed its name to Canadian Natural Resources Limited in December 1975. Canadian Natural Resources Limited was incorporated in 1973 and is headquartered in Calgary, Canada.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 6.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -3.52 > 1.0 |
| NWC/Revenue: -2.63% < 20% (prev -3.05%; Δ 0.41% < -1%) |
| CFO/TA 0.17 > 3% & CFO 14.77b > Net Income 6.66b |
| Net Debt (17.16b) to EBITDA (17.63b): 0.97 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.07b) vs 12m ago -3.00% < -2% |
| Gross Margin: 31.02% > 18% (prev 0.27%; Δ 3075 % > 0.5%) |
| Asset Turnover: 53.48% > 50% (prev 54.77%; Δ -1.29% > 0%) |
| Interest Coverage Ratio: 10.83 > 6 (EBITDA TTM 17.63b / Interest Expense TTM 812.0m) |
Altman Z'' 2.69
| A: -0.01 (Total Current Assets 7.18b - Total Current Liabilities 8.31b) / Total Assets 85.59b |
| B: 0.34 (Retained Earnings 28.91b / Total Assets 85.59b) |
| C: 0.11 (EBIT TTM 8.79b / Avg Total Assets 80.33b) |
| D: 0.90 (Book Value of Equity 40.46b / Total Liabilities 45.13b) |
| Altman-Z'' Score: 2.69 = A |
Beneish M -2.83
| DSRI: 1.16 (Receivables 3.75b/3.10b, Revenue 42.97b/41.12b) |
| GMI: 0.87 (GM 31.02% / 27.05%) |
| AQI: 1.43 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 1.04 (Revenue 42.97b / 41.12b) |
| TATA: -0.09 (NI 6.66b - CFO 14.77b) / TA 85.59b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of CNQ shares?
As of February 27, 2026, the stock is trading at USD 43.09 with a total of 7,770,918 shares traded.
Over the past week, the price has changed by +1.39%, over one month by +19.53%, over three months by +30.97% and over the past year by +58.54%.
Over the past week, the price has changed by +1.39%, over one month by +19.53%, over three months by +30.97% and over the past year by +58.54%.
Is CNQ a buy, sell or hold?
Canadian Natural Resources has received a consensus analysts rating of 4.05.
Therefore, it is recommended to buy CNQ.
- StrongBuy: 8
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CNQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37 | -14.2% |
| Analysts Target Price | 37 | -14.2% |
CNQ Fundamental Data Overview February 21, 2026
Market Cap CAD = 120.85b (88.38b USD * 1.3673 USD.CAD)
P/E Trailing = 18.1974
P/E Forward = 20.0803
P/S = 2.2885
P/B = 2.8441
P/EG = 3.7458
Revenue TTM = 42.97b CAD
EBIT TTM = 8.79b CAD
EBITDA TTM = 17.63b CAD
Long Term Debt = 16.44b CAD (from longTermDebt, last quarter)
Short Term Debt = 829.0m CAD (from shortTermDebt, last quarter)
Debt = 17.27b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.16b CAD (from netDebt column, last quarter)
Enterprise Value = 138.00b CAD (120.85b + Debt 17.27b - CCE 113.0m)
Interest Coverage Ratio = 10.83 (Ebit TTM 8.79b / Interest Expense TTM 812.0m)
EV/FCF = 16.97x (Enterprise Value 138.00b / FCF TTM 8.13b)
FCF Yield = 5.89% (FCF TTM 8.13b / Enterprise Value 138.00b)
FCF Margin = 18.93% (FCF TTM 8.13b / Revenue TTM 42.97b)
Net Margin = 15.49% (Net Income TTM 6.66b / Revenue TTM 42.97b)
Gross Margin = 31.02% ((Revenue TTM 42.97b - Cost of Revenue TTM 29.64b) / Revenue TTM)
Gross Margin QoQ = 48.39% (prev 23.87%)
Tobins Q-Ratio = 1.61 (Enterprise Value 138.00b / Total Assets 85.59b)
Interest Expense / Debt = 0.54% (Interest Expense 93.0m / Debt 17.27b)
Taxrate = 24.23% (1.95b / 8.06b)
NOPAT = 6.66b (EBIT 8.79b * (1 - 24.23%))
Current Ratio = 0.86 (Total Current Assets 7.18b / Total Current Liabilities 8.31b)
Debt / Equity = 0.43 (Debt 17.27b / totalStockholderEquity, last quarter 40.46b)
Debt / EBITDA = 0.97 (Net Debt 17.16b / EBITDA 17.63b)
Debt / FCF = 2.11 (Net Debt 17.16b / FCF TTM 8.13b)
Total Stockholder Equity = 40.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.28% (Net Income 6.66b / Total Assets 85.59b)
RoE = 16.47% (Net Income TTM 6.66b / Total Stockholder Equity 40.42b)
RoCE = 15.46% (EBIT 8.79b / Capital Employed (Equity 40.42b + L.T.Debt 16.44b))
RoIC = 11.47% (NOPAT 6.66b / Invested Capital 58.07b)
WACC = 6.14% (E(120.85b)/V(138.12b) * Re(6.96%) + D(17.27b)/V(138.12b) * Rd(0.54%) * (1-Tc(0.24)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.57%
[DCF] Terminal Value 85.26% ; FCFF base≈8.79b ; Y1≈8.73b ; Y5≈9.11b
[DCF] Fair Price = 112.6 (EV 251.70b - Net Debt 17.16b = Equity 234.54b / Shares 2.08b; r=6.14% [WACC]; 5y FCF grow -1.45% → 2.90% )
EPS Correlation: -87.47 | EPS CAGR: -56.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: -18.70 | Revenue CAGR: -1.81% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.70 | Chg7d=+0.004 | Chg30d=-0.146 | Revisions Net=-3 | Analysts=5
EPS next Year (2026-12-31): EPS=2.71 | Chg7d=+0.015 | Chg30d=-0.028 | Revisions Net=-8 | Growth EPS=-19.1% | Growth Revenue=-7.5%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.5% (Discount Rate 7.9% - Earnings Yield 5.5%)
[Growth] Growth Spread = -15.8% (Analyst -13.4% - Implied 2.5%)
P/E Trailing = 18.1974
P/E Forward = 20.0803
P/S = 2.2885
P/B = 2.8441
P/EG = 3.7458
Revenue TTM = 42.97b CAD
EBIT TTM = 8.79b CAD
EBITDA TTM = 17.63b CAD
Long Term Debt = 16.44b CAD (from longTermDebt, last quarter)
Short Term Debt = 829.0m CAD (from shortTermDebt, last quarter)
Debt = 17.27b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.16b CAD (from netDebt column, last quarter)
Enterprise Value = 138.00b CAD (120.85b + Debt 17.27b - CCE 113.0m)
Interest Coverage Ratio = 10.83 (Ebit TTM 8.79b / Interest Expense TTM 812.0m)
EV/FCF = 16.97x (Enterprise Value 138.00b / FCF TTM 8.13b)
FCF Yield = 5.89% (FCF TTM 8.13b / Enterprise Value 138.00b)
FCF Margin = 18.93% (FCF TTM 8.13b / Revenue TTM 42.97b)
Net Margin = 15.49% (Net Income TTM 6.66b / Revenue TTM 42.97b)
Gross Margin = 31.02% ((Revenue TTM 42.97b - Cost of Revenue TTM 29.64b) / Revenue TTM)
Gross Margin QoQ = 48.39% (prev 23.87%)
Tobins Q-Ratio = 1.61 (Enterprise Value 138.00b / Total Assets 85.59b)
Interest Expense / Debt = 0.54% (Interest Expense 93.0m / Debt 17.27b)
Taxrate = 24.23% (1.95b / 8.06b)
NOPAT = 6.66b (EBIT 8.79b * (1 - 24.23%))
Current Ratio = 0.86 (Total Current Assets 7.18b / Total Current Liabilities 8.31b)
Debt / Equity = 0.43 (Debt 17.27b / totalStockholderEquity, last quarter 40.46b)
Debt / EBITDA = 0.97 (Net Debt 17.16b / EBITDA 17.63b)
Debt / FCF = 2.11 (Net Debt 17.16b / FCF TTM 8.13b)
Total Stockholder Equity = 40.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.28% (Net Income 6.66b / Total Assets 85.59b)
RoE = 16.47% (Net Income TTM 6.66b / Total Stockholder Equity 40.42b)
RoCE = 15.46% (EBIT 8.79b / Capital Employed (Equity 40.42b + L.T.Debt 16.44b))
RoIC = 11.47% (NOPAT 6.66b / Invested Capital 58.07b)
WACC = 6.14% (E(120.85b)/V(138.12b) * Re(6.96%) + D(17.27b)/V(138.12b) * Rd(0.54%) * (1-Tc(0.24)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.57%
[DCF] Terminal Value 85.26% ; FCFF base≈8.79b ; Y1≈8.73b ; Y5≈9.11b
[DCF] Fair Price = 112.6 (EV 251.70b - Net Debt 17.16b = Equity 234.54b / Shares 2.08b; r=6.14% [WACC]; 5y FCF grow -1.45% → 2.90% )
EPS Correlation: -87.47 | EPS CAGR: -56.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: -18.70 | Revenue CAGR: -1.81% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.70 | Chg7d=+0.004 | Chg30d=-0.146 | Revisions Net=-3 | Analysts=5
EPS next Year (2026-12-31): EPS=2.71 | Chg7d=+0.015 | Chg30d=-0.028 | Revisions Net=-8 | Growth EPS=-19.1% | Growth Revenue=-7.5%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.5% (Discount Rate 7.9% - Earnings Yield 5.5%)
[Growth] Growth Spread = -15.8% (Analyst -13.4% - Implied 2.5%)